WallStreetZenWallStreetZen

NASDAQ: PRTA
Prothena Corp Public Ltd Co Stock Forecast, Predictions & Price Target

Analyst price target for PRTA

Based on 7 analysts offering 12 month price targets for Prothena Corp Public Ltd Co.
Min Forecast
$35.00+41.3%
Avg Forecast
$68.14+175.1%
Max Forecast
$90.00+263.34%

Should I buy or sell PRTA stock?

Based on 7 analysts offering ratings for Prothena Corp Public Ltd Co.
Buy
Strong Buy
2 analysts 28.57%
Buy
3 analysts 42.86%
Hold
2 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PRTA stock forecasts and price targets.

PRTA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-13
lockedlocked$00.00+00.00%2024-02-20
lockedlocked$00.00+00.00%2024-02-16
lockedlocked$00.00+00.00%2024-02-16
lockedlocked$00.00+00.00%2024-01-30
Cantor Fitzgerald
Top 3%
98
Strong BuyMaintains$87.00+251.23%2024-01-09
Deutsche Bank
Top 11%
90
Strong BuyInitiates Coverage On$62.00+150.30%2023-12-12

1 of 1

Forecast return on equity

Is PRTA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.27%

Forecast return on assets

Is PRTA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

PRTA revenue forecast

What is PRTA's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$20.5M-77.6%
Avg 2 year Forecast
$138.0M+51.08%
Avg 3 year Forecast
$215.6M+136%
PRTA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PRTA revenue growth forecast

How is PRTA forecast to perform vs Biotechnology companies and vs the US market?
Company
34.5%
Industry
39.22%
Market
10.52%
PRTA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PRTA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PRTA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PRTA$24.77$68.14+175.10%Buy
ABCL$4.53$14.33+216.40%Strong Buy
OCUL$9.10$16.00+75.82%Buy
XNCR$22.13$34.67+56.65%Buy
VRNA$16.09$32.50+101.99%Buy

Prothena Public Co Stock Forecast FAQ

Is Prothena Public Co Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: PRTA) stock is to Buy PRTA stock.

Out of 7 analysts, 2 (28.57%) are recommending PRTA as a Strong Buy, 3 (42.86%) are recommending PRTA as a Buy, 2 (28.57%) are recommending PRTA as a Hold, 0 (0%) are recommending PRTA as a Sell, and 0 (0%) are recommending PRTA as a Strong Sell.

If you're new to stock investing, here's how to buy Prothena Public Co stock.

What is PRTA's revenue growth forecast for 2024-2026?

(NASDAQ: PRTA) Prothena Public Co's forecast annual revenue growth rate of 34.5% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Prothena Public Co's revenue in 2024 is $91,370,000.On average, 5 Wall Street analysts forecast PRTA's revenue for 2024 to be $1,099,550,273, with the lowest PRTA revenue forecast at $48,348,410, and the highest PRTA revenue forecast at $2,686,022,750. On average, 5 Wall Street analysts forecast PRTA's revenue for 2025 to be $7,415,464,167, with the lowest PRTA revenue forecast at $4,096,721,898, and the highest PRTA revenue forecast at $16,116,136,500.

In 2026, PRTA is forecast to generate $11,583,956,593 in revenue, with the lowest revenue forecast at $6,500,175,055 and the highest revenue forecast at $15,059,455,150.

What is PRTA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: PRTA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is PRTA's Price Target?

According to 7 Wall Street analysts that have issued a 1 year PRTA price target, the average PRTA price target is $68.14, with the highest PRTA stock price forecast at $90.00 and the lowest PRTA stock price forecast at $35.00.

On average, Wall Street analysts predict that Prothena Public Co's share price could reach $68.14 by Mar 13, 2025. The average Prothena Public Co stock price prediction forecasts a potential upside of 175.1% from the current PRTA share price of $24.77.

What is PRTA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: PRTA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.